Affiliation:
1. George Emil Palade University of Medicine, Pharmacy, Science and Technology , Department of Pharmacology
2. Department of Pharmacology, Faculty of Medicine in English , George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures , Romania
Abstract
Abstract
Objective: Cholesterol is one of the cardiovascular risk factors, but also a core component of the central nervous system. Moreover, hyper-cholesterolemia and hypocholesterolemia are directly related to numerous mental illnesses too. This study intents to examine the association between cholesterol level and autolytic behavior among female psychiatric patients. Methods: The present study involves 123 female subjects, who suffered from suicidal thoughts at the moment of hospitalization. The risk of suicidal intentions was assessed by the Modified Scale for Suicide Ideation (Miller et al) and their total serum cholesterol levels were measured. We performed a case-control, analytical, randomized, observational study at the Clinical Hospital of Neurology and Psychiatry Brasov among adult female psychiatric patients admitted during 2014. Results: By our results we distinguished 3 categories: 38 patients with low suicide risk, 32 with moderate risk and 53 with high suicide risk. Significant difference can be noticed in the higher suicide risk patients’ blood cholesterol levels: 44 patients having under 4,5mmol/L total cholesterol level (83%). Although, in other two categories, this proportion is minimal: in the moderate-risk category were 8 patients, representing just 25 %, and in the low-risk category only 1 patient had her cholesterol level under 4,5mmol/L (2,6%). Conclusions: According to our results, proposing cholesterol-level as a biomarker for the determination of high-risk suicide behavior can be important. The presence of other important risk factors (sociodemographic and psychiatric variables) can increase exponentially the suicide behavior. The limitations of this study are the relatively small number of cases and the lack of longitudinal subsequent follow-up. Further investigations are needed on a larger and more heterogenous sample of patients in order to clarify this suggestive correlation.
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Dentistry
Reference18 articles.
1. 1. Shneideman E. Definition of suicide. Jason Aronson, Northvale, NJ, 1985: 23-43.
2. 2. Hjelmeland H. Suicide research and prevention: The Importance of Culture in “Biological Times.”In: Colucci E, Lester D (szerk.), Suicide and Culture. Hogrefe, Cambridge: 2013: 3-23.
3. 3. WHO, 2014 Preventing suicide: A global imperative. World Health Organization. http://www.who.int/mental_health/suicide-prevention/world_report_2014/en/
4. 4. Mann JJ. (2003) Neurobiology of suicidal behaviour. Nat Rev Neurosci, 4(10): 819-828.
5. 5. Coryell W, Schlesser M. (2001) The Dexamethasone Suppression Test and Suicide Prediction. Am J Psychiatry, 158(5): 748–753.